Both in Pharmaceuticals
Apimeds Pharmaceuticals US vs Traws Pharma
Over the past year APUS returned −88.0% and TRAW returned −87.4%; their daily moves had a correlation of -0.00.
APUS −88.0% TRAW −87.4%Growth of $1, one year, split-adjusted
| Metric | APUS | TRAW |
|---|---|---|
| Price | $2.97 | $0.3020 |
| Market cap | $4.5M | $4.6M |
| Today | +2.77% | +0.57% |
| 1 month | −35.3% | −43.7% |
| 6 months | −90.1% | −80.9% |
| Year to date | −81.9% | −73.3% |
| 1 year | — | −88.2% |
| Revenue growth (YoY) | — | −100.0% |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | -$8.6M | $5.0M |
| Dividend yield | — | — |
| Volatility (60d) | 264.0% | 79.4% |
| Short % of float | 0.9% | 5.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).